PT82812B - Process for the preparation of new para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylaminopropanol-2-s having beta receptor blocking properties and of pharmaceutical compositions containing the same - Google Patents

Process for the preparation of new para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylaminopropanol-2-s having beta receptor blocking properties and of pharmaceutical compositions containing the same

Info

Publication number
PT82812B
PT82812B PT82812A PT8281286A PT82812B PT 82812 B PT82812 B PT 82812B PT 82812 A PT82812 A PT 82812A PT 8281286 A PT8281286 A PT 8281286A PT 82812 B PT82812 B PT 82812B
Authority
PT
Portugal
Prior art keywords
piperidinecarbonylaminoalkylaminopropanol
phenoxy
substituted
preparation
pharmaceutical compositions
Prior art date
Application number
PT82812A
Other languages
English (en)
Other versions
PT82812A (en
Inventor
Tommy Ingemar Abrahamsson
Bill Benjamin Rudolf
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of PT82812A publication Critical patent/PT82812A/pt
Publication of PT82812B publication Critical patent/PT82812B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT82812A 1985-06-20 1986-06-20 Process for the preparation of new para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylaminopropanol-2-s having beta receptor blocking properties and of pharmaceutical compositions containing the same PT82812B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8503088A SE8503088D0 (sv) 1985-06-20 1985-06-20 New para-substituted 3-phenoxy-1-piperidinecarbonyl-aminoalkylamino-propanol-2-s having beta receptor blocking properties

Publications (2)

Publication Number Publication Date
PT82812A PT82812A (en) 1986-07-01
PT82812B true PT82812B (en) 1988-06-17

Family

ID=20360664

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82812A PT82812B (en) 1985-06-20 1986-06-20 Process for the preparation of new para-substituted 3-phenoxy-1-piperidinecarbonylaminoalkylaminopropanol-2-s having beta receptor blocking properties and of pharmaceutical compositions containing the same

Country Status (14)

Country Link
JP (1) JPS61293968A (pt)
KR (1) KR870000297A (pt)
CN (1) CN86104789A (pt)
AU (1) AU5850586A (pt)
DD (1) DD246109A5 (pt)
DK (1) DK287486A (pt)
FI (1) FI862601A (pt)
GR (1) GR861584B (pt)
HU (1) HUT42067A (pt)
IL (1) IL79037A0 (pt)
NO (1) NO862241L (pt)
PT (1) PT82812B (pt)
SE (1) SE8503088D0 (pt)
ZA (1) ZA864173B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103804349A (zh) * 2012-11-01 2014-05-21 杨子娇 一类治疗青光眼的化合物及其用途

Also Published As

Publication number Publication date
DK287486D0 (da) 1986-06-19
NO862241L (no) 1986-12-22
FI862601A (fi) 1986-12-21
NO862241D0 (no) 1986-06-05
PT82812A (en) 1986-07-01
FI862601A0 (fi) 1986-06-18
DD246109A5 (de) 1987-05-27
GR861584B (en) 1986-10-21
SE8503088D0 (sv) 1985-06-20
CN86104789A (zh) 1987-02-04
ZA864173B (en) 1987-02-25
HUT42067A (en) 1987-06-29
DK287486A (da) 1986-12-21
AU5850586A (en) 1987-01-15
JPS61293968A (ja) 1986-12-24
KR870000297A (ko) 1987-02-17
IL79037A0 (en) 1986-09-30

Similar Documents

Publication Publication Date Title
PT85329A (en) Process for the preparation of tetrahydronaphtaline and indane derivatives and of pharmaceutical compositions containing the same
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
PT84936A (en) Process for the preparation of tetrahydronaphthaline and indanederivatives and of pharmaceutical compositions containing the same
PT86236A (en) Process for the preparation of catechol derivatives and of pharmaceutical compositions containing them
PT81015A (en) Process for the preparation of bicyclic compounds and of pharmaceutical compositions containing
PT85762A (en) Process for the preparation of new cephem compounds and pharmaceutical compositions containing same
HU902693D0 (en) Process for the preparation of n-heteroaryl-4-quinolin-amine compounds and pharmaceutical compositions containing them
PT86365A (en) Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same
PT83260A (en) Process for the preparation of spergualin telated compounds and of pharmaceutical compositions containing them
EG17710A (en) Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them
PT84358A (en) Process for the preparation of naphthothiazepinones and of pharmaceutical compositions containing the same
PT82984A (en) Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same
PT86407A (en) Process for the preparation of new alkanesulfonanilide derivatives and pharmaceutical compositions comprising the same
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
PT80854A (en) Process for preparing of the tricyclic dihydropyridazinones and pharmaceutical compositions containing them
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
PT82395B (en) Process for the preparation of synthetic derivatives of pseudopterosin and of pharmaceutical compositions containing the same
PT82399A (en) Process for the preparation of phenethanolamine derivatives and of pharmaceutical compositions containing the same
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
PT82464A (en) Process for the preparation of novel benzisoselenazolonyl derivatives and of pharmaceutical compositions containing the same
PT79113B (en) Process for the preparation of 16-fluoro-16,17-didehydro prostanoids and of pharmaceutical compositions containing the same
PT81083A (en) Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same
PT82665A (en) Process for the preparation of 11beta-substituted steroids and of pharmaceutical or veterinary compositions containing the same
PT75265B (en) Process for the preparation of diazabicyclicononanes substituted and pharmaceutical composition containing them
PT81759A (en) Process for the preparation of 8-alpha-acylamino ergolines and of pharmaceutical compositions containing them